MONOCLONAL IDIOTYPIC AND ANTIIDIOTYPIC ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN

被引:11
作者
BRODEUR, BR [1 ]
FAUCHER, S [1 ]
OSHAUGHNESSY, MV [1 ]
HAMEL, J [1 ]
机构
[1] FED CTR AIDS,OTTAWA,ONTARIO,CANADA
关键词
D O I
10.1099/0022-1317-72-1-51
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Murine monoclonal antibodies (MAbs) gp41-1 (IgG2a) and gp41-2 (IgG1), directed against the envelope glycoprotein of human immunodeficiency virus type 1 (HIV-1), were produced and characterized. These MAbs recognized both gp160 and gp41 and reacted with divergent HIV-1 isolates. Surface binding assays using viable HIV-infected cells indicated that these MAbs were directed against surface-exposed epitopes. Both MAbs caused a reduction in reverse transcriptase activity. Syngeneic monoclonal anti-idiotypic antibodies (anti-ids) against gp41-1 were also generated. Six anti-ids (agp41-11 to agp41-16) were selected by ELISA using F(ab')2 fragments of gp41-1; no reaction was observed when fragments from an irrelevant IgG2a MAb were used. Anti-ids were recognized by both gp41-1 and gp41-2 biotinylated MAbs. Competitive ELISA studies suggested that anti-ids were directed against at least three distinct idiotopes on gp41-1. All anti-ids reacted with idiotopes associated with both heavy and light chains and not with separated chains. The binding of MAbs gp41-1 and gp41-2 to HlV-infected cells was inhibited by each anti-id, except for the binding of gp41-2 which was not affected by the presence of agp41-12. Immunization of rabbits with agp41-11 and agp41-13 resulted in an antibody response against recombinant gp160. These studies indicated that these two anti-ids contain a surrogate image of the antigen recognized by gp41-1.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 50 条
[21]   MONOCLONAL-ANTIBODIES DIRECTED AGAINST THE REV PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
VOLL, R ;
AEPINUS, C ;
KRAPF, F ;
HERRMANN, M ;
KALDEN, JR ;
FLECKENSTEIN, B .
MOLECULAR AND CELLULAR PROBES, 1990, 4 (01) :63-72
[22]   CONFRONTING THE HYPERVARIABILITY OF AN IMMUNODOMINANT EPITOPE ELICITING VIRUS NEUTRALIZING ANTIBODIES FROM THE ENVELOPE GLYCOPROTEIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) [J].
NEURATH, AR ;
STRICK, N .
MOLECULAR IMMUNOLOGY, 1990, 27 (06) :539-549
[23]   ENZYME-IMMUNOASSAY USING NATIVE ENVELOPE GLYCOPROTEIN (GP160) FOR DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ANTIBODIES [J].
NAIR, BC ;
FORD, G ;
KALYANARAMAN, VS ;
ZAFARI, M ;
FANG, C ;
SARNGADHARAN, MG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (06) :1449-1456
[24]   VACCINE-INDUCED ANTIBODIES TO NATIVE AND RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS [J].
GORSE, GJ ;
FREY, SE ;
PATEL, G ;
NEWMAN, FK ;
BELSHE, RB ;
SCHWARTZ, D ;
CLEMENTS, ML ;
KEEFER, M ;
ROBERTS, N ;
DOLIN, R ;
MCELRATH, J ;
COREY, L ;
GRAHAM, BS ;
WRIGHT, P ;
MATTHEWS, T ;
BOLOGNESI, D ;
WALKER, MC ;
FAST, P ;
FERNIE, BF .
VACCINE, 1994, 12 (10) :912-918
[25]   PRODUCTION OF SITE-SELECTED NEUTRALIZING HUMAN MONOCLONAL-ANTIBODIES AGAINST THE 3RD VARIABLE DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN [J].
GORNY, MK ;
XU, JY ;
GIANAKAKOS, V ;
KARWOWSKA, S ;
WILLIAMS, C ;
SHEPPARD, HW ;
HANSON, CV ;
ZOLLAPAZNER, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (08) :3238-3242
[26]   IDENTIFICATION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR POLYMORPHIC ANTIGENIC DETERMINANTS WITHIN THE V2 REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN [J].
SHOTTON, C ;
ARNOLD, C ;
SATTENTAU, Q ;
SODROSKI, J ;
MCKEATING, JA .
JOURNAL OF VIROLOGY, 1995, 69 (01) :222-230
[27]   A MONOCLONAL-ANTIBODY DIRECTED TO SULFATIDE INHIBITS THE BINDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ENVELOPE GLYCOPROTEIN TO MACROPHAGES BUT NOT THEIR INFECTION BY THE VIRUS [J].
SEDDIKI, N ;
RAMDANI, A ;
SAFFAR, L ;
PORTOUKALIAN, J ;
GLUCKMAN, JC ;
GATTEGNO, L .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1994, 1225 (03) :289-296
[28]   THE ROLE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS IN VIRUS-INFECTION [J].
FREED, EO ;
MARTIN, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) :23883-23886
[29]   STUDIES ON THE ROLE OF THE V3-LOOP IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN FUNCTION [J].
CHOU, SH ;
FREED, EO ;
PANGANIBAN, AT ;
KENEALY, WR .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (09) :1611-1618
[30]   RAPID COMPLEMENTATION ASSAYS MEASURING REPLICATIVE POTENTIAL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN MUTANTS [J].
HELSETH, E ;
KOWALSKI, M ;
GABUZDA, D ;
OLSHEVSKY, U ;
HASELTINE, W ;
SODROSKI, J .
JOURNAL OF VIROLOGY, 1990, 64 (05) :2416-2420